Innovative Solutions for Drug Discovery and Development

USD 950

* Required Fields

USD 950


Be the first to review this product

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across novel methods that improve drug discovery. The service encompasses recent advances in drug discovery technologies that impact precision oncology, targeted cancer therapy, Big Data analytics and Parkinson’s disease management. Lastly, the TOE summarizes key technology trends that leverage stem cell platforms for advancing drug discovery.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Drug discovery, biofluorescence, cancer detection, genome analytics, precision oncology, Big Data analytics, cancer vaccines, cancer biosimilar, Parkinson ’s disease, non-small cell lung cancer (NSCLC), NR0B1, NR0B1, induced pluripotent stem cell (iPSC)

Table of Contents

Innovative Solutions for Drug Discovery and DevelopmentDriving New Approaches To Enhance Drug DiscoveryBiofluorescence Platform for Early Cancer DetectionAdvanced Genome Analytics for Precision OncologyIntelligent Driven Therapeutics DiscoveryCancer Vaccines Advancing Clinical TrialsFirst FDA Approved Biosimilar for Treatment of Cancer FDA-approved Treatment for Parkinson’s Disease Associated Hallucinations and DelusionsDiscovery of Novel Anti-cancer TherapiesDrug DiscoveryTechnology Focus and TrendsTechnology Focus and TrendsCompanies to WatchIndustry Interactions




Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Related Subscription

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.